Left Atrial Appendage Closure: Implantation Depth Could Determine Thrombosis Risk

Left atrial appendage closure (LAAC) has undergone significant advances over the past two decades. This progress has been driven by the development of new devices, improved procedural safety, and the growing body of evidence supporting broader clinical adoption. Despite these advances, device-related thrombosis (DRT) remains a major concern because of its association with an increased risk of thromboembolic events. Several risk factors for DRT have been identified, although most are non-modifiable. 

Among the few modifiable factors, deep device implantation has consistently emerged as one of the most significant predictors of DRT across multiple studies. Distal device implants leave a relevant portion of the left atrium exposed to blood stasis around the device surface, potentially promoting thrombus formation.

Recent advances in computational fluid dynamics (CFD) modeling have enabled patient-specific blood flow simulations to assess the risk of device-related thrombosis after LAAC. These simulations have provided valuable insights into the relationship between left atrial appendage anatomy, hemodynamics, and thrombus development. However, previous studies have been limited by small sample sizes, restricting the generalizability of their findings.

The aim of this study was to evaluate the impact of device implantation depth on blood flow dynamics after LAAC using CFD-based simulations and to explore its potential role in DRT risk stratification.

Read also: Influence of cusp-overlap and three-cusp coplanar techniques on new-onset conduction disturbances after TAVI.

The Primary Endpoint (PEP) was to compare CFD-derived flow indices — device surface velocity index (DSVI), endothelial cell activation potential (ECAP), and the presence of vortices/stagnant flow — between proximal and distal implantation groups. The Secondary Endpoint (SEP) was to explore the relationship between these flow characteristics and the rate of DRT.

The study included 285 patients who underwent LAAC with Amplatzer Amulet or WATCHMAN devices across 10 centers. Patient-specific CFD simulations were performed using postprocedural computed tomography and echocardiography to assess blood flow dynamics. The mean age was 75 years, and most patients were male.

Read also: Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak.

Proximal implants (57.2%) demonstrated more favorable flow patterns, including higher DSVI (0.11 m/s vs. 0.09 m/s; p = 0.002), lower ECAP (0.75 vs. 0.90; p = 0.003), and fewer recirculation zones (40.5% vs. 74.6%; p < 0.001). The incidence of DRT increased with greater implantation depth, in parallel with worsening flow indices. A CFD-based DRT risk score incorporating ECAP, implantation depth, and flow complexity showed good discriminatory capacity (ROC area under the curve [AUC] 0.81), outperforming anatomical depth alone (AUC 0.71).

Conclusion: Greater implantation depth after LAAC is associated with abnormal blood flow dynamics and a worse hemodynamic profile

The use of CFD simulations in patients undergoing LAAC demonstrated a clear relationship between deeper distal implantation and abnormal flow patterns associated with a higher risk of device-related thrombosis (DRT). These findings highlight the close relationship between altered blood flow dynamics and thrombus formation.

Título Original: Impact of device implantation depth on blood flow dynamics after left atrial appendage closure.

Referencia: Pedro Cepas-Guillén et al EuroIntervention 2026;22:e444-e454.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...